Last Price
0.004
Today's Change
+0.001 (33.33%)
Day's Change
0.004 - 0.004
Trading Volume
15,250,756
Overview
Market Cap
8 Million
Shares Outstanding
2 Billion
Avg Volume
3,637,432
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
0.00
EPS
0.00
Earnings Announcement
26-Feb-2025
Previous Close
0.00
Open
0.00
Day's Range
0.004 - 0.004
Year Range
0.001 - 0.005
Trading Volume
15,250,756
Price Change Highlight
1 Day Change
33.33%
5 Day Change
100.00%
1 Month Change
33.33%
3 Month Change
60.00%
6 Month Change
33.33%
Ytd Change
33.33%
1 Year Change
33.33%
3 Year Change
-73.33%
5 Year Change
33.33%
10 Year Change
-93.79%
Max Change
-96.59%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
Australia’s Social Media Ban for Children Under 16 to Become Law
2
CEO Morning Brief
Meta, TikTok, Google Slam Australia’s Under-16 Social Media Ban
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
